rx 821002 has been researched along with Allodynia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Castro Perez, A; de Francischi, JN; Gama Duarte, ID; Romero, TR | 1 |
| Houghton, AK; Westlund, KN | 1 |
2 other study(ies) available for rx 821002 and Allodynia
| Article | Year |
|---|---|
Probable involvement of alpha(2C)-adrenoceptor subtype and endogenous opioid peptides in the peripheral antinociceptive effect induced by xylazine.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Analgesics; Animals; Dinoprostone; Dose-Response Relationship, Drug; Hyperalgesia; Idazoxan; Imidazoles; Leucine; Male; Naloxone; Opioid Peptides; Pain; Pain Measurement; Rats; Rats, Wistar; Xylazine; Yohimbine | 2009 |
An I2 imidazoline ligand, RS 45041, potentiates hyperalgesia in acute arthritis.
Topics: Acute Disease; Adrenergic alpha-Antagonists; Animals; Arthritis; Drug Evaluation, Preclinical; Drug Synergism; Hyperalgesia; Idazoxan; Imidazoles; Imidazoline Receptors; Indoles; Injections, Spinal; Isoindoles; Neural Inhibition; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Drug | 1996 |